Toward an integrated understanding of fibromyalgia syndrome. I. Medical and pathophysiological aspects
暂无分享,去创建一个
[1] W. Müller. The fibrositis syndrome: diagnosis, differential diagnosis and pathogenesis. , 1987, Scandinavian journal of rheumatology. Supplement.
[2] E. Boland. Psychogenic Rheumatism: The Musculoskeletal Expression of Psychoneurosis * , 1947, Annals of the rheumatic diseases.
[3] T. Merigan,et al. Clinical and immunologic effects of recombinant leukocyte A interferon in eight patients with advanced cancer. , 1982, JAMA.
[4] A Lecture on Lumbago: Its Lessons and Analogues , 1904, British medical journal.
[5] R. Stockman. The Causes, Pathology, and Treatment of Chronic Rheumatism , 1904, Edinburgh Medical Journal.
[6] G. A. Mccain,et al. Evaluation of amitriptyline in primary fibrositis. A double-blind, placebo-controlled study. , 1986, Arthritis and rheumatism.
[7] Awad Ea. Interstitial myofibrositis: hypothesis of the mechanism. , 1973 .
[8] G. Asboe-hansen,et al. Morphological and Chemical Connective Tissue Changes in Fibrositic Muscles * , 1957, Annals of the rheumatic diseases.
[9] R. Bennett. Fibrositis: misnomer for a common rheumatic disorder. , 1981, The Western journal of medicine.
[10] M. Yunus,et al. Is chronic pain a variant of depressive disease? The case of primary fibromyalgia syndrome , 1987, Pain.
[11] G. A. Mccain,et al. The concept of primary fibromyalgia (fibrositis): clinical value, relation and significance to other chronic musculoskeletal pain syndromes , 1988, Pain.
[12] Dr. med. Hans Georg Fassbender. Pathology of Rheumatic Diseases , 1975, Springer Berlin Heidelberg.
[13] R. Bennett,et al. Aerobic fitness in patients with fibrositis. A controlled study of respiratory gas exchange and 133xenon clearance from exercising muscle. , 1989, Arthritis and rheumatism.
[14] H. Moldofsky,et al. Sleep and posttraumatic rheumatic pain modulation disorder (fibrositis syndrome). , 1986, Psychosomatic medicine.
[15] M. Yunus,et al. Concepts of illness in populations as applied to fibromyalgia syndromes. , 1986, The American journal of medicine.
[16] H. Moldofsky,et al. Dysthymic Disorder and Rheumatic Pain Modulation Disorder (Fibrositis Syndrome): A Comparison of Symptoms and Sleep Physiology * , 1986, Canadian journal of psychiatry. Revue canadienne de psychiatrie.
[17] F. Wolfe,et al. Socioeconomic impact of fibrositis. A study of 81 patients with primary fibrositis. , 1986, The American journal of medicine.
[18] M. Yunus,et al. Plasma tryptophan and other amino acids in primary fibromyalgia: a controlled study. , 1992, The Journal of rheumatology.
[19] X. Caro. Immunofluorescent detection of IgG at the dermal-epidermal junction in patients with apparent primary fibrositis syndrome. , 1984, Arthritis and rheumatism.
[20] I. Russell,et al. Is there a metabolic basis for the fibrositis syndrome? , 1986, The American journal of medicine.
[21] A. Komaroff,et al. The "chronic, active Epstein-Barr virus infection" syndrome and primary fibromyalgia. , 1987, Arthritis and rheumatism.
[22] F. Wolfe,et al. Fibrositis: symptom frequency and criteria for diagnosis. An evaluation of 291 rheumatic disease patients and 58 normal individuals. , 1985, The Journal of rheumatology.
[23] W. Clark,et al. Pain sensitivity, mood and plasma endocrine levels in man following long-distance running: Effects of naloxone , 1984, Pain.
[24] M. Yunus,et al. Serum β-endorphin in primary fibromyalgia syndrome: a controlled study , 1986 .
[25] E. Beutner,et al. Immunopathology of the skin , 1987 .
[26] A. Bengtsson,et al. MUSCLE BIOPSY FINDINGS OF POSSIBLE DIAGNOSTIC IMPORTANCE IN PRIMARY FIBROMYALGIA (FIBROSITIS, MYOFASCIAL SYNDROME) , 1982, The Lancet.
[27] H. Moldofsky,et al. Sleep and musculoskeletal pain. , 1986, The American journal of medicine.
[28] F. Wolfe. The clinical syndrome of fibrositis. , 1986, The American journal of medicine.
[29] F. Wolfe,et al. Pain, functional disability, and psychological status: a 12-month study of severity in fibromyalgia. , 1988, The Journal of rheumatology.
[30] L. Boccassini,et al. Double-Blind Study of Dothiepin versus Placebo in the Treatment of Primary Fibromyalgia Syndrome , 1987, The Journal of international medical research.
[31] M. Yunus,et al. Juvenile primary fibromyalgia syndrome. A clinical study of thirty-three patients and matched normal controls. , 1985, Arthritis and rheumatism.
[32] G. A. Mccain. Role of physical fitness training in the fibrositis/fibromyalgia syndrome. , 1986, The American journal of medicine.
[33] H. Moldofsky. Sleep and fibrositis syndrome. , 1989, Rheumatic diseases clinics of North America.
[34] B. Danneskiold-Samsøe,et al. Isometric and isokinetic muscle strength in patients with fibrositis syndrome. New characteristics for a difficult definable category of patients. , 1987, Scandinavian journal of rheumatology.
[35] K. Mašek,et al. Muramyl Peptides, Serotonergic System, and Sleep , 1987, Annals of the New York Academy of Sciences.
[36] G. Hanks. Psychotropic drugs. , 1984, Postgraduate medical journal.
[37] H. Moldofsky,et al. Two contributions to understanding of the "fibrositis" syndrome. , 1977, Bulletin on the rheumatic diseases.
[38] A. Hartz,et al. Undetected fibrositis in primary care practice. , 1987, The Journal of family practice.
[39] H. Moldofsky. Nonrestorative sleep and symptoms after a febrile illness in patients with fibrositis and chronic fatigue syndromes. , 1989, The Journal of rheumatology. Supplement.
[40] F. Wolfe,et al. Prevalence of primary and secondary fibrositis. , 1983, The Journal of rheumatology.
[41] D. Goldenberg,et al. Psychiatric and psychologic aspects of fibromyalgia syndrome. , 1989, Rheumatic diseases clinics of North America.
[42] L. Terenius,et al. Endorphins in chronic pain. I. Differences in CSF endorphin levels between organic and psychogenic pain syndromes , 1978, Pain.
[43] D. Felson,et al. A prospective evaluation of 118 patients with the fibromyalgia syndrome: prevalence of Raynaud's phenomenon, sicca symptoms, ANA, low complement, and Ig deposition at the dermal-epidermal junction. , 1986, The Journal of rheumatology.
[44] M. Yunus,et al. A controlled study of primary fibromyalgia syndrome: clinical features and association with other functional syndromes. , 1989, The Journal of rheumatology. Supplement.
[45] O. Gutiérrez-Rodríguez,et al. Treatment of refractory rheumatoid arthritis--the thalidomide experience. , 1989, The Journal of rheumatology.
[46] J. Neubauer,et al. Sleep, sleep apnea and the fibromyalgia syndrome. , 1986, The Journal of rheumatology.
[47] H. Moldofsky,et al. The relationship of alpha and delta EEG frequencies to pain and mood in 'fibrositis' patients treated with chlorpromazine and L-tryptophan. , 1980, Electroencephalography and clinical neurophysiology.
[48] P. Hauri,et al. Alpha-delta sleep. , 1973, Electroencephalography and clinical neurophysiology.
[49] D. Felson,et al. The natural history of fibromyalgia. , 1986, Arthritis and rheumatism.
[50] Burda Cd. Immunoglobulin-G deposits at the dermal-epidermal junction in secondary (traumatic) fibromyalgia syndrome. , 1984 .
[51] P. Tugwell,et al. The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. , 1990, Arthritis and rheumatism.
[52] Wilke Ws,et al. Proposed pathogenesis of fibrositis. , 1985 .
[53] D. Felson,et al. Tenderness in 75 anatomic sites. Distinguishing fibromyalgia patients from controls. , 1988, Arthritis and rheumatism.
[54] D. Wallace,et al. Cytokines and immune regulation in patients with fibrositis. , 1989, Arthritis and rheumatism.
[55] R. Feldman,et al. Fundamentals of neuropsychopharmacology , 1984 .
[56] R. Bennett,et al. A double blind crossover trial of prednisone versus placebo in the treatment of fibrositis. , 1985, The Journal of rheumatology.
[57] M. Yunus,et al. Serum beta-endorphin in primary fibromyalgia syndrome: a controlled study. , 1986, Journal of Rheumatology.
[58] A. Komaroff,et al. The chronic fatigue syndrome: definition, current studies and lessons for fibromyalgia research. , 1989, The Journal of rheumatology. Supplement.
[59] H. Moldofsky,et al. Musculosketal Symptoms and Non‐REM Sleep Disturbance in Patients with “Fibrositis Syndrome” and Healthy Subjects , 1975, Psychosomatic medicine.
[60] X. Caro. Immunofluorescent studies of skin in primary fibrositis syndrome. , 1986, The American journal of medicine.
[61] M. Yunus,et al. Muscle biopsy findings in primary fibromyalgia and other forms of nonarticular rheumatism. , 1989, Rheumatic diseases clinics of North America.
[62] G. Ferraccioli,et al. EMG-biofeedback training in fibromyalgia syndrome. , 1987, The Journal of rheumatology.
[63] G. Norman,et al. Tender points in fibromyalgia , 1988, Pain.
[64] B. Farrington,et al. The medical works of Hippocrates , 1950 .
[65] V. Harber,et al. Endorphins and Exercise , 1984, Sports medicine.
[66] Patrick D. Wall,et al. Challenge Of Pain , 1983 .
[67] F. Wolfe. Development of criteria for the diagnosis of fibrositis. , 1986, The American journal of medicine.
[68] L. Terenius,et al. Cerebrospinal fluid levels of beta-endorphin in patients with fibromyalgia (fibrositis syndrome). , 1988, The Journal of rheumatology.
[69] M. Karnovsky,et al. Sleep and the Immune Response , 1987, Annals of the New York Academy of Sciences.
[70] M. Yunus,et al. Pathologic changes in muscle in primary fibromyalgia syndrome. , 1986, The American journal of medicine.
[71] D. Goldenberg. Fibromyalgia and its relation to chronic fatigue syndrome, viral illness and immune abnormalities. , 1989, The Journal of rheumatology. Supplement.
[72] M. Yunus,et al. Primary fibromyalgia (fibrositis): clinical study of 50 patients with matched normal controls. , 1981, Seminars in arthritis and rheumatism.
[73] Caro Xj. Is there an immunologic component to the fibrositis syndrome , 1989 .
[74] H. Moldofsky,et al. Induction of Neurasthenic Musculoskeletal Pain Syndrome by Selective Sleep Stage Deprivation , 1976, Psychosomatic medicine.
[75] H Merskey,et al. Psychiatry and Chronic Pain , 1989, Canadian journal of psychiatry. Revue canadienne de psychiatrie.
[76] N. Hadler. Medical Management of the Regional Musculoskeletal Diseases: Backache, Neck Pain, Disorders of the Upper and Lower Extremities , 1984 .
[77] M. Millan. Multiple opioid systems and pain , 1986, Pain.
[78] L. Terenius,et al. Elevated CSF levels of substance P and high incidence of Raynaud phenomenon in patients with fibromyalgia: new features for diagnosis , 1988, Pain.
[79] L. Terenius,et al. Substance P in CSF of patients with chronic pain syndromes , 1988, Pain.
[80] Y. Lurie,et al. fibrositis : a therapeutic trial . Imipramine for the treatment of , 2022 .
[81] Morgane Pj. Monoamine theories of sleep: the role of serotonin--a review [proceedings]. , 1981 .
[82] B. Danneskiold-Samsøe,et al. HISTOLOGICAL ABNORMALITIES IN MUSCLE FROM PATIENTS WITH CERTAIN TYPES OF FIBROSITIS , 1986, The Lancet.
[83] D. Felson,et al. A randomized, controlled trial of amitriptyline and naproxen in the treatment of patients with fibromyalgia. , 1986, Arthritis and rheumatism.
[84] F. Wolfe,et al. Fibrositis (Fibromyalgia) in rheumatoid arthritis. , 1984, The Journal of rheumatology.
[85] R. Bennett,et al. Clinical characteristics of fibrositis. I. A "blinded," controlled study of symptoms and tender points. , 1983, Arthritis and rheumatism.
[86] N. Hadler. A critical reappraisal of the fibrositis concept. , 1986, The American journal of medicine.
[87] F. Wolfe,et al. A controlled and blinded study of immunoreactant deposition at the dermal-epidermal junction of patients with primary fibrositis syndrome. , 1986, The Journal of rheumatology.
[88] H. Nielsen,et al. Reduced blood flow in fibromyotic muscles during ultrasound therapy. , 2020, Scandinavian journal of rehabilitation medicine.
[89] D. Wallace,et al. Fibromyalgia and interleukin-2 therapy for malignancy. , 1988, Annals of internal medicine.
[90] L. Jorfeldt,et al. Primary Fibromyalgia: A Clinical and Laboratory Study of 55 Patients , 1986 .